A provider's guide to vascular disease, dyslipidemia, and glycemic dysregulation in chronic spinal cord injury

Michael Stillman, Savalan Babapoor-Farrokhran, Ronald Goldberg, David R. Gater

Research output: Contribution to journalArticlepeer-review

Abstract

Individuals with chronic spinal cord injury (SCI) are predisposed to accelerated atherogenesis, dyslipidemia, and glycemic dysregulation, although not enough is known about the etiologies or clinical consequences of these secondary effects of paralysis. While guidelines for the detection and treatment of cardiometabolic disease in SCI have recently been published, there has been a historical paucity of data-driven approaches to these conditions. This article will describe what is and not known about the cardiovascular disease and glycemic dysregulation that frequently attend SCI. It will conclude with a review of both guidelinedriven and informal recommendations addressing the clinical care of people living with SCI.

Original languageEnglish (US)
Pages (from-to)203-208
Number of pages6
JournalTopics in Spinal Cord Injury Rehabilitation
Volume26
Issue number3
DOIs
StatePublished - Jun 2020
Externally publishedYes

Keywords

  • Dyslipidemia
  • Glycemic dysregulation
  • Spinal cord injury
  • Vascular disease

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation
  • Clinical Neurology

Fingerprint Dive into the research topics of 'A provider's guide to vascular disease, dyslipidemia, and glycemic dysregulation in chronic spinal cord injury'. Together they form a unique fingerprint.

Cite this